Paclitaxel/gemcitabine administered every two weeks in advanced breast cancer: Preliminary results of a phase II trial

1. Colomer, R.
2. Llombart, A.
3. Lluch, A.
4. Ojeda, B.
5. Barnadas, A.
6. Caranana, V.
7. Fernandez, Y.
8. De Paz, L.
9. Guillem, V.
10. Alonso, S.